Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Dexamethasone Therapy in VLBW Infants at Risk of CLD

ClinicalTrials.gov ID: NCT00011362

Public ClinicalTrials.gov record NCT00011362. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Clinical Trial of Dexamethasone Therapy in Very-Low-Birth-Weight Infants at Risk for Chronic Lung Disease (CLD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Infants who are on breathing support are often treated with steroids (dexamethasone); however, the best timing of therapy is not known. This trial looked at the benefits and hazards of starting dexamethasone therapy at two weeks of age and four weeks of age in premature infants.

Study identification

NCT ID
NCT00011362
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
371 participants

Conditions and interventions

Eligibility (public fields only)

Age range
13 Days to 15 Days
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 1992 (Type not available)
Primary completion
Jan 1994 (Actual)
Completion
Apr 1994 (Actual)
Last update posted
Mar 22, 2019

1992 – 1994

United States locations

U.S. sites
13
U.S. states
12
U.S. cities
13
Facility City State ZIP Site status
Stanford University Palo Alto California 94304 —
Yale University New Haven Connecticut 06504 —
George Washington University Washington D.C. District of Columbia 20052 —
University of Miami Miami Florida 33136 —
Emory University Atlanta Georgia 30303 —
Indiana University Indianapolis Indiana 46202 —
Wayne State University Detroit Michigan 48201 —
University of New Mexico Albuquerque New Mexico 87131 —
Cincinnati Children's Medical Center Cincinnati Ohio 45267 —
Case Western Reserve University, Rainbow Babies and Children's Hospital Cleveland Ohio 44106 —
Brown University, Women & Infants Hospital of Rhode Island Providence Rhode Island 02905 —
University of Tennessee Memphis Tennessee 38163 —
University of Texas Southwestern Medical Center at Dallas Dallas Texas 75235 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00011362, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 22, 2019 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00011362 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →